about
Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.The Crucial Involvement of Retinoid X Receptors in DDE Neurotoxicity.RXRα, PXR and CAR xenobiotic receptors mediate the apoptotic and neurotoxic actions of nonylphenol in mouse hippocampal cells.Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia.Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`.Effects of melatonin in a place preference conditioning depend on the time of administration.Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1/ESR1 protein levels but not ESR2 and AHR/ARNT signaling.Effects of chronic mild stress on the development of drug dependence in rats.Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ERα and PPAR-γ.Apoptotic and neurotoxic actions of 4-para-nonylphenol are accompanied by activation of retinoid X receptor and impairment of classical estrogen receptor signaling.Isomer-nonspecific action of dichlorodiphenyltrichloroethane on aryl hydrocarbon receptor and G-protein-coupled receptor 30 intracellular signaling in apoptotic neuronal cells.Negative Allosteric Modulators of mGlu Receptor as Putative Antipsychotic DrugsPrenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARγ Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain NeuronsPrenatal exposure to benzophenone-3 (BP-3) induces apoptosis, disrupts estrogen receptor expression and alters the epigenetic status of mouse neurons.Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
P50
Q35171790-5AC3725A-758E-4FA4-AB8D-45C2667CE30FQ35840360-13958CCD-0D78-4349-A251-D599BB0EE4ECQ40235704-0D961861-3423-4AAD-A01D-FDB8533090F6Q40420216-1F11DBA6-3EBA-473A-83BF-4399CDF21B0CQ41310518-7760977A-2A4D-4FDF-8F0C-4E21950EC699Q42754406-E2DA35B2-39A8-4D47-AB86-D983D6BACBD2Q47838753-647AB1AD-937E-431B-B7DD-A8BE28417A1AQ47854838-F6C2CD92-2BB6-4886-A2D1-D0BFF6CBAF0AQ47874995-20747D0E-E6FA-4AAB-A296-EE9B78AD7B82Q48620844-0F5544A0-3D84-44CF-B41C-BFC877A72F8DQ48769603-070D9F90-3E87-4C5B-8D6B-D9EA943B876DQ57191778-ADE44C19-4B61-4EBD-853B-E6D64458C907Q58608074-CEA2D2FE-FE9C-425F-B33E-991FF5A3E196Q67496242-298B7A2F-E0AF-4A20-A6EB-B44A41EA416CQ67496265-D940BED6-6B50-411C-9601-A43F385974F0Q67874267-95110F8D-9FCA-443D-AC01-A27367B1E628
P50
description
investigador
@es
researcher
@en
name
Ewa Litwa
@en
type
label
Ewa Litwa
@en
prefLabel
Ewa Litwa
@en
P31
P496
0000-0003-2392-4647